OrbiMed Genesis GP LLC, Director, 10% Owner at MBX Biosciences, Inc. (MBX), bought 257,704 shares at $9.90 ($2.7M) on 2025-02-14, disclosed to the SEC on 2025-02-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.85 | 29,540 | $291K | 10.7% |
| 2 | $9.90 | 17,962 | $178K | 6.5% |
| 3 | $9.90 | 17,962 | $178K | 6.5% |
| 4 | $10.84 | 49,070 | $532K | 19.5% |
| 5 | $10.84 | 49,070 | $532K | 19.5% |
| 6 | $10.84 | 94,100 |
| $1.0M |
| 37.4% |
| Total | $10.60 avg | 257,704 | $2.7M | 100% |
| Filing → |
| KROS | SELL | 2024-08-15 | $11.0M | — | Filing → |
| TERN | SELL | 2024-07-17 | $562K | — | Filing → |
| IRON | BUY | 2024-06-20 | $3.0M | — | Filing → |